JEFF just out - On the Road W/ Mgmt -- Would Buy for HemeA and Robust Pipeline BUY $19 TP | SGMO Message Board Posts

Sangamo Therapeutics, Inc.

  SGMO website

SGMO   /  Message Board  /  Read Message

 

 






Keyword
Subject
Between
and
Rec'd By
Authored By
Minimum Recs
  
Previous Message  Next Message   Post Message   Post a Reply return to message boardtop of board
Msg  130251 of 130701  at  7/12/2019 11:57:08 AM  by

MaxPowerNGS


 In response to msg 130241 by  marcbull99
view thread

Re: JEFF just out - On the Road W/ Mgmt -- Would Buy for HemeA and Robust Pipeline BUY $19 TP

>>> " Did anybody note that it looks like Sanofi has treated 2 more Beta Thal subjects . So it is now clear they will have results from at least 3 subjects at ASH in December."
 
Agreed.  I would also say that ASH is shaping up to be a shock and awe event for SGMO. HemoA durability and BetaThal (plus, something on SCD?).  Follow that with an update of IVPRP probably around JPM. 
 
The Winter of 19/20 will be exciting.


     e-mail to a friend      printer-friendly     add to library      
| More
Recs: 13     Views: 428
Previous Message  Next Message   Post Message   Post a Reply return to message boardtop of board


About Us    Contact Us    Follow Us on Twitter    Members Directory    Help Center    Advertise
Not a member yet? What are you waiting for? Create Account
Want to contribute? Support InvestorVillage by donating
2003-2018 Investorvillage.com. All rights reserved. User Agreement
   
Financial Market Data provided by
.


Loading...